Health Condition 1: N915- Oligomenorrhea, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Menses at an interval longer than 35 days. 2.Subjects aged from 15 35 years. 3.Bleeding less than 2 days. 4.Both married and unmarried. 5.Subject willing for consent.
Exclusion criteria
Exclusion criteria: 1.Lactating women. 2.Woman on OCPs and IUCD. 3.Hb% less than 7 gm. 4.Known case of Pelvic Pathology or Malignancy. 5.Known case of PCOS Condition
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of Trial Drug on Improvement in the symptoms of Artavakshaya(Oligo-hypomenorrhoea)Timepoint: Every 5th day of Menstrual cycle for 3 consecutive cycles | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of trial drug and Adverse Drug Reaction Aggravation of Symptoms of ArtavakshayaTimepoint: Every 5th day of Menstrual cycle for 3 consecutive cycles | — |
Countries
India
Contacts
SDMTs AMC Post Graduation Centre Terdal